Co-Administration of Vadimezan and Recombinant Coagulase-NGR Inhibits Growth of Melanoma Tumor in Mice

Purpose: Tumor vascular targeting appeared as an appealing approach to fight cancer, though, the results from the clinical trials and drugs in the market were proved otherwise. The promise of anti-angiogenic therapy as the leading tumor vascular targeting strategy was negatively affected with the di...

Full description

Bibliographic Details
Main Authors: Amir Daei Farshchi Adli, Rana Jahanban-Esfahlan, Khaled Seidi, Davoud Farajzadeh, Ramezan Behzadi, Nosratollah Zarghami
Format: Article
Language:English
Published: Tabriz University of Medical Sciences 2021-02-01
Series:Advanced Pharmaceutical Bulletin
Subjects:
Online Access:https://apb.tbzmed.ac.ir/PDF/apb-11-385.pdf